On August 27, the "15th Five-Year Plan for Health Development in Fujian Province" was officially released, outlining key initiatives for the upcoming period.

Among the highlighted measures, the plan emphasizes deepening cross-strait integration in the healthcare sector to foster a new landscape of open, regional development. It calls for strengthening collaboration between Fujian and Taiwan in the medical and health industries, particularly in areas such as biopharmaceutical research and development, prevention of major diseases, and cutting-edge medical technology studies.

A significant focus is placed on supporting the construction of a cross-strait cooperation zone dedicated to biotechnology and healthcare industries. Additionally, the plan aims to enhance pharmaceutical integration across the strait by encouraging the introduction of innovative drugs and medical devices already approved for market in Taiwan, facilitating their application within medical institutions in Fujian Province.

Furthermore, the initiative includes backing for Fujian University of Traditional Chinese Medicine in establishing a key laboratory dedicated to cross-strait integration in traditional Chinese medicine, signaling a commitment to advancing collaborative research and innovation in this field.